Thursday, May 09, 2013

Drug company that supported Obamacare now says rebate plan could be ‘catastrophic’

Eli Lilly CEO John Lechleiter, who previously lobbied on behalf of Obamacare, said that one of President Obama’s costly new health-care reforms would have “catastrophic” consequences for innovation and that he plans to fight against it.
Read the compete article by Patrick Howley at The Daily Caller.

More health reform information on the Obamacare page.